| Added by | mollevi |
|---|---|
| Last modified by | standudu |
| Group name | EquipeVC |
| Item Type | Journal Article |
| Title | Role of sclerostin and dickkopf-1 in the dramatic alteration in bone mass acquisition in adolescents and young women with recent anorexia nervosa |
| Creator | Maimoun et al. |
| Author | L. Maimoun |
| Author | S. Guillaume |
| Author | P. Lefebvre |
| Author | P. Philibert |
| Author | H. Bertet |
| Author | M. C. Picot |
| Author | L. Gaspari |
| Author | F. Paris |
| Author | P. Courtet |
| Author | E. Thomas |
| Author | D. Mariano-Goulart |
| Author | J. Bringer |
| Author | E. Renard |
| Author | C. Sultan |
| Abstract | BACKGROUND: The nutritional deprivation of adolescent girls with anorexia nervosa (AN) reduces bone mass acquisition. A better understanding of this process would improve the medical treatment of bone alteration and its long-term consequences. OBJECTIVE: The first aim was to model the bone mass acquisition in young women with AN. The second aim was to identify the clinical and biological factors associated with bone demineralization and investigate the potential role of sclerostin and dickkopf-1 protein (DKK-1). POPULATION AND METHODS: Ninety-eight AN patients (mean age 18.2 +/- 2.6 years) and 63 age-matched controls were enrolled in this study. Areal bone mineral density (aBMD) was determined by dual-energy x-ray absorptiometry. Calciotropic hormones, bone turnover markers, sclerostin, DKK-1, and growth factors were concomitantly evaluated. RESULTS: The aBMD was significantly reduced at all bone sites in AN patients vs controls (range, -3.3% at the radius to -12.1% for total proximal femur). Bone formation markers IGF-1 and DKK-1 were significantly decreased in AN patients, whereas PTH, sclerostin, and the bone resorption markers were increased. In patients, the AN duration, amenorrhea, weight, body mass index, fat mass, and fat-free soft tissue were negatively correlated with aBMD, whereas the age of AN onset was positively correlated. Multiple regression analysis revealed that the duration of amenorrhea was the independent factor most negatively associated with aBMD at all bone sites except the radius. CONCLUSION: This case-control study demonstrated a dramatic reduction in aBMD, reinforced for the first time by our models, and indicates the need for early, systematic, and adapted bone mass monitoring. Moreover, appropriate treatment should be started early in patients with AN. Increased secretion of sclerostin suggests that it may be a target for pharmacological action. |
| Publication | J Clin Endocrinol Metab |
| Volume | 99 |
| Pages | E582-90 |
| Date | Apr 2014 |
| Journal Abbr | The Journal of clinical endocrinology and metabolism |
| DOI | 10.1210/jc.2013-2565 |
| ISSN | 1945-7197 (Electronic) 0021-972X (Linking) |
| Extra | 00000 |
| Tags | *Bone Density/drug effects, *Osteogenesis/drug effects, Adolescent, Adult, Anorexia Nervosa/*blood/*physiopathology, Biological Markers/blood, Body Mass Index, Bone and Bones/drug effects/metabolism, Bone Morphogenetic Proteins/*physiology, Case-Control Studies, clinic, Contraceptives, Oral/pharmacology, Female, Genetic Markers/*physiology, Humans, Intercellular Signaling Peptides and Proteins/*physiology, Young Adult |
| Date Added | 2018/11/14 - 12:10:52 |
| Date Modified | 2019/06/06 - 22:43:29 |
| Notes and Attachments | (Note) (Note) 24471564 (Attachment) |
Institut de Recherche en Cancérologie de
